These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38819384)

  • 1. S100A1's single cysteine is an indispensable redox switch for the protection against diastolic calcium waves in cardiomyocytes.
    Seitz A; Busch M; Kroemer J; Schneider A; Simon S; Jungmann A; Katus HA; Most P; Ritterhoff J
    Am J Physiol Heart Circ Physiol; 2024 Jul; 327(1):H000. PubMed ID: 38819384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A1 DNA-based Inotropic Therapy Protects Against Proarrhythmogenic Ryanodine Receptor 2 Dysfunction.
    Ritterhoff J; Völkers M; Seitz A; Spaich K; Gao E; Peppel K; Pleger ST; Zimmermann WH; Friedrich O; Fink RHA; Koch WJ; Katus HA; Most P
    Mol Ther; 2015 Aug; 23(8):1320-1330. PubMed ID: 26005840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A1 decreases calcium spark frequency and alters their spatial characteristics in permeabilized adult ventricular cardiomyocytes.
    Völkers M; Loughrey CM; Macquaide N; Remppis A; DeGeorge BR; Wegner FV; Friedrich O; Fink RH; Koch WJ; Smith GL; Most P
    Cell Calcium; 2007 Feb; 41(2):135-43. PubMed ID: 16919727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
    Bovo E; Mazurek SR; Zima AV
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes.
    Brinks H; Rohde D; Voelkers M; Qiu G; Pleger ST; Herzog N; Rabinowitz J; Ruhparwar A; Silvestry S; Lerchenmüller C; Mather PJ; Eckhart AD; Katus HA; Carrel T; Koch WJ; Most P
    J Am Coll Cardiol; 2011 Aug; 58(9):966-73. PubMed ID: 21851887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+ signaling in mouse cardiomyocytes with ablated S100A1 protein.
    Gusev K; Ackermann GE; Heizmann CW; Niggli E
    Gen Physiol Biophys; 2009 Dec; 28(4):371-83. PubMed ID: 20097960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac hypertrophy associated with impaired regulation of cardiac ryanodine receptor by calmodulin and S100A1.
    Yamaguchi N; Chakraborty A; Huang TQ; Xu L; Gomez AC; Pasek DA; Meissner G
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H86-94. PubMed ID: 23666671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes.
    Kettlewell S; Most P; Currie S; Koch WJ; Smith GL
    J Mol Cell Cardiol; 2005 Dec; 39(6):900-10. PubMed ID: 16236309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocytes, endothelial cells and cardiac fibroblasts: S100A1's triple action in cardiovascular pathophysiology.
    Rohde D; Busch M; Volkert A; Ritterhoff J; Katus HA; Peppel K; Most P
    Future Cardiol; 2015 May; 11(3):309-21. PubMed ID: 26021637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.
    Terentyev D; Györke I; Belevych AE; Terentyeva R; Sridhar A; Nishijima Y; de Blanco EC; Khanna S; Sen CK; Cardounel AJ; Carnes CA; Györke S
    Circ Res; 2008 Dec; 103(12):1466-72. PubMed ID: 19008475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRIC-A Channel Maintains Store Calcium Handling by Interacting With Type 2 Ryanodine Receptor in Cardiac Muscle.
    Zhou X; Park KH; Yamazaki D; Lin PH; Nishi M; Ma Z; Qiu L; Murayama T; Zou X; Takeshima H; Zhou J; Ma J
    Circ Res; 2020 Feb; 126(4):417-435. PubMed ID: 31805819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Fernández-Velasco M; Rueda A; Rizzi N; Benitah JP; Colombi B; Napolitano C; Priori SG; Richard S; Gómez AM
    Circ Res; 2009 Jan; 104(2):201-9, 12p following 209. PubMed ID: 19096022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ero1α-Dependent ERp44 Dissociation From RyR2 Contributes to Cardiac Arrhythmia.
    Hamilton S; Terentyeva R; Bogdanov V; Kim TY; Perger F; Yan J; Ai X; Carnes CA; Belevych AE; George CH; Davis JP; Gyorke S; Choi BR; Terentyev D
    Circ Res; 2022 Mar; 130(5):711-724. PubMed ID: 35086342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required.
    Venetucci LA; Trafford AW; Eisner DA
    Circ Res; 2007 Jan; 100(1):105-11. PubMed ID: 17110597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKA phosphorylation of cardiac ryanodine receptor modulates SR luminal Ca2+ sensitivity.
    Ullrich ND; Valdivia HH; Niggli E
    J Mol Cell Cardiol; 2012 Jul; 53(1):33-42. PubMed ID: 22487381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Impact of Ryanodine Receptor Oxidation on Intracellular Calcium Regulation in the Heart.
    Zima AV; Mazurek SR
    Rev Physiol Biochem Pharmacol; 2016; 171():39-62. PubMed ID: 27251471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
    Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
    Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.
    Curran J; Hinton MJ; Ríos E; Bers DM; Shannon TR
    Circ Res; 2007 Feb; 100(3):391-8. PubMed ID: 17234966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance.
    Most P; Remppis A; Pleger ST; Löffler E; Ehlermann P; Bernotat J; Kleuss C; Heierhorst J; Ruiz P; Witt H; Karczewski P; Mao L; Rockman HA; Duncan SJ; Katus HA; Koch WJ
    J Biol Chem; 2003 Sep; 278(36):33809-17. PubMed ID: 12777394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.